ArticleHardwareX2021
Automated melt electrowritting platform with real-time process monitoring.
Article in HardwareX, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Redesigning FDM Platforms for Bio-Printing Applications.Micromachines · 2025Review
- Towards industry-ready additive manufacturing: AI-enabled closed-loop control for 3D melt electrowriting.Communications engineering · 2024Article
- Advances in melt electrowriting for cardiovascular applications.Frontiers in bioengineering and biotechnology · 2024Review
- Filament-Based Melt Electrowriting Enables Dual-Mode Additive Manufacturing for Multiscale Constructs.Small science · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Melt electrowriting (MEW) is an additive manufacturing (AM) technology with the ability to fabricate complex designs with high-resolution. The utility of MEW is studied in many fields including tissue engineering and soft robotics. However, current MEW hardware offers only basic functionality and is often designed and built in-house. This affects results replication across different MEW devices and slows down the technological advancement. To address these issues, we present an automated MEW platform with real-time process parameter monitoring and control. We validate the developed platform by demonstrating the ability to accurately print polymer structures and successfully measure and adjust parameters during the printing process. The platform enables the collection of large volumes of data that can be subsequently used for further analysis of the system. Ultimately, the concept will help MEW to become more accessible for both research laboratories and industry and allow advancing the technology by leveraging the process monitoring, control and data collection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.